e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Diffuse parenchymal lung diseases: experimental animal studies and case reports
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Blockage of serotonin receptors and transporter reduces bleomycin lung fibrosis in mice
A. Fabre, J. Marchand, S. Marchand-Adam, J. Callebert, J. M. Launay, C. Ruffié, P. Soler, B. Crestani (Paris, France)
Source:
Annual Congress 2005 - Diffuse parenchymal lung diseases: experimental animal studies and case reports
Session:
Diffuse parenchymal lung diseases: experimental animal studies and case reports
Session type:
Thematic Poster Session
Number:
617
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Fabre, J. Marchand, S. Marchand-Adam, J. Callebert, J. M. Launay, C. Ruffié, P. Soler, B. Crestani (Paris, France). Blockage of serotonin receptors and transporter reduces bleomycin lung fibrosis in mice. Eur Respir J 2005; 26: Suppl. 49, 617
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
Source: Eur Respir J 2008; 32: 426-436
Year: 2008
Naftopidil, a selective a1 adrenoceptor antagonist, inhibits the growth of lung fibroblasts and attenuates bleomycin-induced lung fibrosis in mice
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation
Source: Eur Respir J 2005; 26: Suppl. 49, 82s
Year: 2005
SD-208 an orally active TGF-β1 receptor antagonist inhibits TGF-β1 induced progressive lung fibrosis in rat
Source: Annual Congress 2003 - Animal models of lung injury: useful or not?
Year: 2003
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Year: 2019
Role of leukotriene receptor antagonist on TGF-β1 and Smad signalling in bleomycin induced pulmonary fibrosis
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
Hypoxia-mediated alterations in adenosine receptor expression in rat lung
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
PAR-2 antagonist inhibits bleomycin-induced lung fibrosis.
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
Effect of dexfenfluramine on the development of pulmonary hypertension in mice over-expressing the serotonin transporter
Source: Eur Respir J 2005; 26: Suppl. 49, 352s
Year: 2005
Endothelin-1 receptor antagonist prevents hyperoxia-induced parenchymal mechanical impairment in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 334s
Year: 2004
Decreased expression of the phosphatidylserine receptor in lung emphysema
Source: Eur Respir J 2004; 24: Suppl. 48, 96s
Year: 2004
Expression of TGF-β and TGFβ receptors in bleomycin-induced pulmonary fibrosis of rats
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002
Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
Reduction in serotonin signaling via TPH1 inhibition attenuates the progression of PAH in mice with genetic ablation of endothelial BMPR-II
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012
RAGE deficiency improves alveolar fluid clearance in LPS-induced acute lung injury by preventing downregulation of Na-K-ATPase and ENaC
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Effects of tachykinin receptor antagonists on lung function and plasma extravasation induced by HCl intraoesophageal instillation in rabbits
Source: Eur Respir J 2001; 18: Suppl. 33, 257s
Year: 2001
Concomitant exposure to nicotine and endotoxin in vitro induces murine airway hyperreactivity possibly via nicotine-induced upregulation of toll-like receptors
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Reduction of endogenous acetylcholine contributes to pulmonary inflammation in a model of emphysema in mice
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept